EssilorLuxottica announces agreement for acquisition of Espansione Group

News
Article

Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

A person in a business suit holds a lit-up lightbulb. Image credit: ©kamiphotos – stock.adobe.com

The transaction is subject to local regulatory review, EssilorLuxottica said. Image credit: ©kamiphotos – stock.adobe.com

EssilorLuxottica has entered an agreement for the acquisition of Espansione Group.

Espansione Group, based in Italy, specialises in the design and manufacturing of non-invasive medical devices, protected by international patents, for the diagnosis and treatment of dry-eye, ocular surface and retinal diseases. Espansione Group is known for photobiomodulation (PBM) technology – the Light Modulation Low-level Light Therapy (LLLT), which is used in ophthalmology and dermatology, along with the Intense Pulsed Light (IPL) technology.1

For EssilorLuxottica, this agreement marks a further step into the med-tech space, and it is consistent with the Group’s strategy to elevate industry standards and improve the quality of patient care solutions, the company said in a press release.1

Francesco Milleri, Chairman and Chief Executive Officer at EssilorLuxottica, commented on this agreement in the company’s press release.1 He said, “We are pleased to welcome the pioneering Espansione into our Group. This investment, proudly made in one of our home countries, will expand our portfolio of medical devices and solidify our role in the optical industry. EssilorLuxottica’s med-tech journey, aimed at elevating vision health standards, will continue to be an open and collaborative one, where our products and services are accessible to all industry players.”

This transaction is subject to local regulatory review and other customary closing conditions.

Reference:

1. EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space. EssilorLuxottica. December 16, 2024. Accessed December 16, 2024. https://www.espansionegroup.it/newsroom/essilorluxottica-signs-agreement-acquire-espansione-accelerating-growth-med-tech/

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.